I'm expecting that Conneqt Pulse will be " the real deal ", FDA...

I'm expecting that Conneqt Pulse will be " the real deal ", FDA cleared ... as opposed to the GTH Pro which is a non-FDA cleared smartwatch from Mobvoi and is only ever meant to give " General Health Direction", not clinical advice. Clearance will mean that Cardiex has demonstrated that the Pulse is "substantially equivalent to ATCOR SphygmoCor(R) XCEL" that already has FDA clearance, and will have successfully moved our technology into the hands of the consumer.

With the Conneqt Pulse FDA cleared I also expect full endorsement from a major pharmaceutical company, such as Bayer, to rollout the Conneqt Pulse across all their clinical trials. This will generate revenue well beyond " extreme niche ", and may well be the catalyst to the re-rate of the market capitalisation of the company that many patient investors on this forum have waited for.

The next 6 months promises to be the most exciting time in this companies history.
Suggest you hang around !

All IMO.
DYOR